Leptomeningeal Carcinomatosis: BRCA-mutation related triple negative breast cancer

Case study 95 - Dr. Grunch explains leptomeningeal disease from breast cancerПодробнее

How are Triple Negative Breast Cancer and BRCA Related?Подробнее

Challenges of treating patients with breast cancer with leptomeningeal metastasisПодробнее

Leptomeningeal Metastases - Mayo ClinicПодробнее

CSF Immune profiling in leptomeningeal disease | Laura Huppert, MD & Chris Im, PhDПодробнее

Triple-Negative Breast Cancer and BRCA MutationsПодробнее

ChemoSymposium 2011: PARP treatment for BRCA mutated and triple negative breast cancerПодробнее

BRCA-Mutated Triple-Negative Breast CancerПодробнее

Triple-Negative Breast Cancer Patients Should Undergo Genetic Screening - Mayo ClinicПодробнее

Immunomodulatory effects of PARP inhibition in BRCA1-deficient triple-negative breast cancerПодробнее

LMD Leptomeningeal DiseaseПодробнее

Diagnosis, Evaluation, & Systemic Management of Leptomeningeal Metastasis - Kester Phillips, M.D.Подробнее

Machine learning identifies risk factors associated with leptomeningeal disease | Ramin Morshed, MDПодробнее

Treating Leptomeningeal Carcinomatosis in Lung CancerПодробнее

Positive BRCA Gene and Breast Cancer | Dr. Rajeev Agarwal | MedantaПодробнее

Understanding BRCA1 and BRCA2: What These Mutations Mean for Breast Cancer RiskПодробнее

2020 TTF EGFR QA Panel Increase in Leptomeningeal Disease & Connection with Mutation Pos. NSCLCПодробнее

BRCA mutation in metastatic TNBC patientsПодробнее

Melanoma Awareness & Leptomeningeal Disease (LMD)Awareness: The Complication No One Talks AboutПодробнее